Collate creates and streamlines documentation for drug development, medical device, and diagnostic companies.
Collate has raised $95.0M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
Collate's investors include Y Combinator, First Round Capital, Redpoint, Conviction Embed.
Collate is headquartered in San Francisco, United States.
Collate creates and streamlines documentation for drug development, medical device, and diagnostic companies.
Collate is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Collate — Funding & Investors." VCBacked, June 3, 2026, https://www.vcbacked.co/company/collate-san-francisco. Accessed September 12, 2026.
VCBacked. (2026). Collate — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/collate-san-francisco
{{cite web |title=Collate — Funding & Investors |url=https://www.vcbacked.co/company/collate-san-francisco |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated